Comment: Big V 'errors' may not be so wrong

clock

Once in a while, someone launches a new financial product on the market which sets everyone in the industry talking - recently it was the unveiling of Virgin Money's Big V direct offer cancer cover.

Much of the publicity and press coverage has been negative about either the marketing tactics employed by Virgin – promoting a product which Virgin stresses is not critical illness cover (CIC) only to compare it with critical illness product premiums – or the fact it is not offered through the advised intermediary channel, as well as questioning whether it actually meets the needs of consumers compared with existing protection products. Only a few months ago, discussion on CI products challenged the status quo and asked whether anything could be done to improve what some touted as a dying...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Your profession

Feel Good Friday: Quilter pledges £3m towards financial education

Feel Good Friday: Quilter pledges £3m towards financial education

Alongside £1m in grants supporting charities

Professional Adviser
clock 13 February 2026 • 1 min read
Brits unlikely to see IFAs despite Budget impact

Brits unlikely to see IFAs despite Budget impact

Just 19% were likely to seek advice, Continuum finds

Isabel Baxter
clock 12 February 2026 • 3 min read
Treasury consults on AR regime adding further FCA and FOS permissions

Treasury consults on AR regime adding further FCA and FOS permissions

Amid concerns about consumer harm and weaknesses in oversight

Isabel Baxter
clock 12 February 2026 • 3 min read